June 26, 2026 Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
June 26, 2026 AVANTIS INVESTORS REACHES $150 BILLION IN ASSETS UNDER MANAGEMENT IN LESS THAN SEVEN YEARS
The book achieved top seller status as a New Release in Vermont Travel Guides category
The book achieved top seller status as a New Release in Vermont Travel Guides category 
